{'fraction_non_alphanumeric': 0.024739583333333332, 'fraction_numerical': 0.0013020833333333333, 'mean_word_length': 5.866071428571429, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Evaluation of the cardiovascular risk associated with atherosclerosis: HDL-cholesterol or apoproteins? (author's transl)].

The antiatherogenic role of HDL-cholesterol is now well established and for some years plasma HDL-cholesterol measurements have been used in the biochemical evaluation of atherosclerosis. A positive correlation has been found between low HDL-cholesterol plasma levels and high risk of cardiovascular complications. More recently, studies of the proteinic component of lipoproteins, particularly apoprotein A 1 of HDL lipoproteins and apoprotein B of LDL and VLDL lipoproteins, have shown that measurement of apoproteins is of greater help to differentiate between normal subjects and patients with coronary artery disease, irrespective of age.